Mouth Bacteria Neisseria flavescens Found to Slow Aging in Animals and Humans
An AI-driven multi-omics framework identifies a common oral bacterium that decelerates biological aging and extends lifespan in animal models.
Summary
Researchers used an AI framework called AURORA to screen the oral microbiome for bacteria that might slow aging. They identified Neisseria flavescens (Nf), a common mouth commensal, as a top candidate. In computer simulations, higher Nf abundance correlated with younger physiological signatures and better gut microbiome composition. Lab experiments confirmed Nf produces beneficial metabolites. In C. elegans worms, live Nf extended both lifespan and healthspan. In aged mice, heat-killed Nf supplementation shifted the serum metabolome, liver gene expression, and gut microbiome toward patterns seen in younger animals. The study positions the oral microbiome as an overlooked but potentially powerful lever for systemic aging, and Nf itself as a candidate probiotic for geroprotective interventions.
Detailed Summary
The gut microbiome has long been linked to aging, but the oral microbiome — despite being the gateway to the entire digestive system — has received far less attention as a modulator of systemic aging. This study from Peking University and collaborating Chinese institutions changes that picture dramatically.
The researchers developed AURORA, a generative AI framework that integrates multi-modality biological data — encompassing microbiome profiles, metabolomics, transcriptomics, and physiological markers — to build multi-modal aging clocks. They then used AURORA to run in silico screens, asking which interventions most effectively reduce the predicted biological age gap. Neisseria flavescens (Nf), a common oral commensal bacterium, emerged as the top hit.
In silico perturbation experiments linked higher Nf abundance to favorable physiological signatures, a healthier gut microbiome composition, and increased biosynthesis of beneficial metabolites. The team isolated two Nf strains and confirmed in vitro that they produce these metabolites. Functional validation in C. elegans showed that live Nf supplementation extended both lifespan and healthspan — a key distinction, measuring quality as well as length of life.
The most translatable animal findings came from aged mice given heat-killed Nf. Supplementation restored the serum metabolome, liver transcriptome, and gut microbiome composition toward states characteriztic of younger animals — three independent systemic markers of biological rejuvenation responding in concert.
Several caveats apply. The full paper has not been reviewed here; this summary is based on the abstract only. The human association between Nf abundance and decelerated aging is correlational, not yet proven causal in people. Animal models — C. elegans and mice — do not always translate to human outcomes. A pending patent held by lead authors on Nf applications introduces a potential competing interest. Nonetheless, this work establishes the oral microbiome as a credible systemic aging axis and Nf as a concrete candidate for probiotic-based geroprotective strategies.
Key Findings
- AI framework AURORA identified Neisseria flavescens as the top in silico hit for reducing biological age gap in humans.
- Live N. flavescens extended lifespan and healthspan in C. elegans worms.
- Heat-killed N. flavescens restored serum metabolome, liver transcriptome, and gut microbiome toward younger states in aged mice.
- Higher oral N. flavescens abundance correlated with favorable gut microbiome composition and beneficial metabolite production.
- Findings reframe the oral microbiome as an underestimated but systemic driver of biological aging.
Methodology
The study used AURORA, a generative multi-modality AI framework integrating microbiome, metabolomic, transcriptomic, and physiological data to build aging clocks and perform in silico intervention screening. Findings were validated sequentially in vitro (metabolite production by isolated Nf strains), in C. elegans lifespan assays, and in aged mouse supplementation experiments measuring serum metabolomics, liver transcriptomics, and gut microbiome composition.
Study Limitations
This summary is based on the abstract only; the full methodology, statistical analyses, and supplementary data have not been reviewed. The human data are associational — causal evidence of Nf slowing aging in people is not yet established. Animal model findings (C. elegans, mice) may not directly translate to human aging biology. Lead authors hold a pending patent on Nf applications, representing a potential conflict of interest.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: